Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Systemic bone marrow disorders: characterization with proton chemical shift imaging.

F Gückel1, G Brix, W Semmler

  • 1German Cancer Research Center, Institute of Radiology and Pathophysiology, Heidelberg.

Journal of Computer Assisted Tomography
|July 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rituximab Chimeric Anti-CD20 Monoclonal Antibody Therapy for Relapsed Indolent Lymphoma: Half of Patients Respond to a Four-Dose Treatment Program.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2023
Same author

An automated approach to determine antibody endpoint titers for COVID-19 by an enzyme-linked immunosorbent assay.

Immunohematology·2021
Same author

Transplant-associated thrombotic microangiopathy is an endothelial complication associated with refractoriness of acute GvHD.

Bone marrow transplantation·2017
Same author

Addition of rituximab to CHOP-like chemotherapy in first line treatment of primary mediastinal B-cell lymphoma.

BMC cancer·2017
Same author

Molecular signaling in multiple myeloma: association of RAS/RAF mutations and MEK/ERK pathway activation.

Oncogenesis·2017
Same author

Strengths and limitations of coronary angiography with turbo high-pitch third-generation dual-source CT.

Clinical radiology·2017

Proton chemical shift imaging (CSI) quantitatively detects reduced bone marrow fat in patients with lymphoma or myelofibrosis. This advanced MRI technique offers superior diagnostic accuracy compared to visual assessment for bone marrow disorders.

Area of Science:

  • Biomedical Imaging
  • Oncology
  • Hematology

Background:

  • Bone marrow disorders, including malignant lymphoma and myelofibrosis, significantly alter marrow composition.
  • Accurate assessment of bone marrow fat and water content is crucial for diagnosis and monitoring.
  • Conventional MRI assessment can be subjective and may miss subtle pathological changes.

Purpose of the Study:

  • To evaluate the efficacy of proton chemical shift imaging (CSI) in quantifying bone marrow fat fractions in patients with bone marrow disorders.
  • To compare the diagnostic performance of quantitative CSI with visual MRI assessment in detecting bone marrow pathology.

Main Methods:

  • Prospective clinical study involving 26 patients (22 with malignant lymphoma, 4 with myelofibrosis) and 9 healthy volunteers.

Related Experiment Videos

  • Utilized conventional magnetic resonance imaging and proton chemical shift imaging (CSI) with a modified Dixon method.
  • Performed quantitative analysis of relative fat and water signal fractions in bone marrow regions of interest (femur, pelvis, spine).

    • Main Results:

    • Chemical shift imaging (CSI) revealed a significant reduction in bone marrow fat fraction in 16 out of 17 patients with biopsy-proven bone marrow disorders compared to healthy volunteers.
    • Quantitative CSI demonstrated higher sensitivity in detecting bone marrow pathology than visual assessment, which identified only 14 of the 17 pathological cases.
    • The modified Dixon method provided reliable quantitative data on bone marrow fat content.

    Conclusions:

    • Proton chemical shift imaging (CSI) is a valuable tool for quantitatively assessing bone marrow fat reduction in patients with malignant lymphoma and myelofibrosis.
    • Quantitative CSI offers improved diagnostic accuracy for bone marrow disorders compared to conventional visual MRI assessment.
    • CSI provides objective and sensitive detection of bone marrow infiltration and fibrosis.